1. Home
  2. VERA vs HG Comparison

VERA vs HG Comparison

Compare VERA & HG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • HG
  • Stock Information
  • Founded
  • VERA 2016
  • HG 2013
  • Country
  • VERA United States
  • HG Bermuda
  • Employees
  • VERA N/A
  • HG N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • HG
  • Sector
  • VERA Health Care
  • HG
  • Exchange
  • VERA Nasdaq
  • HG Nasdaq
  • Market Cap
  • VERA 2.4B
  • HG 1.9B
  • IPO Year
  • VERA 2021
  • HG 2023
  • Fundamental
  • Price
  • VERA $28.58
  • HG $17.83
  • Analyst Decision
  • VERA Buy
  • HG Buy
  • Analyst Count
  • VERA 8
  • HG 7
  • Target Price
  • VERA $66.38
  • HG $21.71
  • AVG Volume (30 Days)
  • VERA 985.9K
  • HG 332.5K
  • Earning Date
  • VERA 03-19-2025
  • HG 02-26-2025
  • Dividend Yield
  • VERA N/A
  • HG N/A
  • EPS Growth
  • VERA N/A
  • HG 537.51
  • EPS
  • VERA N/A
  • HG 4.48
  • Revenue
  • VERA N/A
  • HG $2,266,708,000.00
  • Revenue This Year
  • VERA N/A
  • HG N/A
  • Revenue Next Year
  • VERA N/A
  • HG $7.66
  • P/E Ratio
  • VERA N/A
  • HG $3.97
  • Revenue Growth
  • VERA N/A
  • HG 68.94
  • 52 Week Low
  • VERA $25.99
  • HG $12.44
  • 52 Week High
  • VERA $51.61
  • HG $20.71
  • Technical
  • Relative Strength Index (RSI)
  • VERA 29.57
  • HG 33.94
  • Support Level
  • VERA $25.99
  • HG $17.47
  • Resistance Level
  • VERA $34.79
  • HG $19.04
  • Average True Range (ATR)
  • VERA 2.15
  • HG 0.44
  • MACD
  • VERA -0.56
  • HG -0.12
  • Stochastic Oscillator
  • VERA 20.05
  • HG 20.00

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About HG Hamilton Insurance Group Ltd. Class B

Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in Lloyd's, Ireland, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.

Share on Social Networks: